reSee.it - Related Video Feed

The speaker discusses the spread of bird flu and the potential for mass culling of poultry. They mention the development of bird flu vaccines and the possibility of human-to-human transmission. The conversation also touches on the lack of human trials for vaccines and the FDA's approval process based on preclinical data. The focus is on the need for vaccination, particularly for farm workers.

Vince agrees that flu is a major pathogen with high virulence and transmissibility. Other pathogens may have one but not the other. The panel focuses on flu proposals, which is a common sentiment among those outside the field as well.

We have been studying epidemics for about forty years, particularly looking at the issue of legislation. Working with animals, such as chickens with bronchitis caused by coronavirus, has been somewhat simpler. Despite thirty years of trying various vaccines, we have not been able to control it effectively. So, why is it that we suddenly find a solution for humans when we have struggled to find one for the flu? How can we achieve this?

We need to be proactive in searching for emerging diseases before they become a global threat. Peter Daszak, who collaborated with the Wuhan Institute of Virology, discovered 50 previously unknown Coronaviruses in bats. These Coronaviruses have the potential to jump from wildlife to humans. Our organization works with labs worldwide, subcontracting the work and ensuring we have a country program officer in each location to manage our projects.

The transcript features two speakers discussing crisis communication during an influenza event and a related lecture. In a lecture excerpt from 01/22/2019 at Chatham House, Belgian top virologist Marc Van Ranst is described as explaining how he “fooled the entire Belgian population during the swine flu,” through fear mongering, out of context mortality rates, and media manipulation. The excerpt states that he laughingly explains how he managed to impose the vaccine for the swine flu on the frightened Belgian population, a vaccine produced by the pharmaceutical companies he worked for. Speaker 1, identified as Abbe, thanks the audience and then provides an account of experiences as the crisis manager and flu commissioner for Belgium, focusing on communication. He emphasizes that there is one opportunity to do it right, noting that day one is extremely important. He describes the initial communication strategy: start with one voice and one message. Belgium chose to appoint a non-politician to handle the role, someone with no party affiliations, which he says makes things easier because you are not attacked politically by majority or minority considerations. He notes this as a huge advantage at the time. Speaker 1 further explains that being able to “play in Brussels the complete naive guy” allowed more to get done than would otherwise be possible. He stresses the need to be omnipresent on the first day or the initial days to attract media attention. He mentions making an agreement with the media to tell them everything, implying a transparent or forthcoming approach during the early crisis phase. Overall, the transcript juxtaposes a controversial claim attributed to Van Ranst regarding manipulation and vaccination in Belgium with a practical description of crisis communication strategy in Belgium, emphasizing consistent messaging, nonpartisan leadership, and proactive, pervasive engagement with the media in the crucial early days.

The call aims to unite four public health agencies to discuss the current situation regarding HPAI, particularly H5N1, and to share lessons learned about surveillance and epidemiology. CFIA presented their enhanced poultry surveillance plans, including efforts related to cattle and milk. The UK Health Security Agency shared insights from their asymptomatic human surveillance pilot. Don Sheppard emphasized the need for developing an assay for H5N1 to prepare for potential positive test results. He highlighted the challenges in determining the appropriate populations and techniques for serosurveillance, including the lack of serum samples from humans or cattle with H5N1. Ongoing discussions and work are focused on protocol development to ensure readiness for any developments in the situation.

I have served in 5 administrations and want to emphasize that the next administration will face challenges in infectious diseases. There will be both chronic diseases and surprise outbreaks. History shows that these challenges are inevitable, so it is crucial to be prepared. Many have underestimated infectious diseases, but they remain a significant threat.

The segment centers on the claim that government officials and the biopharma industry are redoing a “bird flu” scare with a high-profile summit in Washington, DC, while pushing vaccines through emergency authorization processes. Key points and claims - BARDA granted Moderna 176 million dollars to accelerate development of an emergency bird flu vaccine. The hosts emphasize that Moderna has never had a product reach the market through standard channels, implying prior success relied on emergency authorizations during the COVID pandemic. - The hosts assert that current bird flu is not contagious between humans and that treatments exist; they question how vaccine development can anticipate mutations “best guess” scenarios. They frame this as a repeat of the COVID playbook: using emergency use authorization to push a vaccine. - They note that the US and EU are reportedly using emergency orders to procure bird flu vaccines from CSL Securus, which they allege is funded and advised by the Bill and Melinda Gates Foundation. - A three-day “International Bird Flu Summit” is described as taking place in early October in Washington, DC, with speakers and breakout sessions. They show the summit website and list breakout topics, including mass fatality management, fatality operations, continuity of government planning, operating with absenteeism, business continuity, remote work policies, and travel policy. - The hosts stress that the breakout sessions cover topics like “mass fatality management planning,” “continuity of government planning,” and “remote work policies,” suggesting the agenda extends beyond purely clinical topics into civil preparedness and governance. - They claim the summit is real and not a conspiracy, showing the conference site, sessions, and a contact phone line. They also note that attendees can pay for sessions (the price cited around $625 to attend) and vendors can participate. - The hosts recount an attempted inquiry to the Bird Flu Summit hotline. A caller (Clayton) asks why the summit is being held now, given bird flu’s long history and purported lack of human fatalities in the US. The response from the hotline staffer is described as evasive; she states this is the organization’s first year doing the conference, mentions “global transfer” and 13 viruses, but does not provide concrete virus-specific evidence to address the questions. The caller reports the staffer hung up after questions about evidence and the focus on population control and remote work. - They reference Dr. Peter McCullough’s stance that bird flu could become a pandemic and that authorities used fear during prior outbreaks. - Dr. Kelly Victory is cited arguing for available and effective medications to treat bird flu (e.g., hydroxychloroquine, ivermectin, steroids) and suggesting that if authorities block these treatments in the name of vaccine deployment, people will resist. They imply mRNA vaccines are being positioned as central to the response, pointing to Forbes reporting on Moderna’s involvement in an mRNA bird flu shot. - The hosts tease future coverage, mentioning Max Jones and Unlimited Hangout, connecting the discussion to the broader narrative that biopharmaceutical interests seek to maintain pandemic preparedness for profit, particularly as profits decline when the public is not in a continual pandemic state. Additional context - The dialogue includes skeptical framing around the necessity and timing of the summit, the motivations behind it, and concerns about surveillance, lockdown readiness, and vaccine deployment. It also notes the appearance of a media segment with a critical stance toward the Bird Flu Summit’s stated goals and potential implications for public health policy.

We need to pay attention to several emerging health threats. Starting January 21st, H5N1 is spreading among wild birds and poultry in the western U.S., with sporadic human cases reported. There's a risk of human-to-human transmission. Additionally, a new coronavirus may be developing in Asia, and mosquito-borne viruses like dengue and Zika could return along the Gulf Coast. Vaccine-preventable diseases are also on the rise due to anti-vaccine sentiments, with a fivefold increase in whooping cough cases and multiple measles outbreaks this year. Polio has been detected in New York's wastewater. A strong response team is essential to address these challenges effectively.

Dr. Cardcaine, an epidemiologist from the University of Michigan, is identified as the person who broke the story in February about a bird flu outbreak linked to the USDA research lab. He states that mainstream media are not reporting on this development. He also asserts that Peter Hotez will not tell the public about this information. According to the speaker, the current strain of bird flu in this outbreak was created in a lab through serial passage conducted in a U.S. government laboratory. The claim specifies that this lab-driven process enabled the virus to jump from traditional chickens to migratory waterfowl. From there, the outbreak purportedly spread to cows, marking a transition from poultry to other species in the ecosystem. The narrative presented emphasizes that the origin and progression of the outbreak are laboratory-generated, rather than arising solely from natural spillover events. The speaker highlights that the virus was manipulated via serial passage in a government lab, a technique used to adapt pathogens to new hosts or improve transmissibility. The sequence described claims a progression: initial adaptation in poultry, transmission to migratory waterfowl, and subsequent appearance in cattle. The speaker underscores two supplementary points: first, that major media outlets have not reported on this angle of the outbreak; second, that a well-known public figure in the field, Peter Hotez, is portrayed as someone who would supposedly not disclose this information. The overall message portrays a narrative of concealment and laboratory involvement in the emergence and spread of the bird flu across species, culminating in its presence in cows. In summary, the speaker attributes the outbreak to deliberate laboratory manipulation via serial passage in a U.S. government facility, tracing a path from chickens to migratory waterfowl and then to cows, while accusing mainstream media of omission and suggesting that Peter Hotez would not disclose these details.

I have served in 5 administrations and want to share my perspective on pandemic preparedness. Based on my experience, I want to emphasize that the coming administration will face challenges in dealing with infectious diseases. This includes both chronic diseases and unexpected outbreaks. The history of the last 32 years as the director of NIAID shows that there is no doubt the next administration will have to confront these challenges.

It seems that bird flu, a gain-of-function strain, is causing concern. The strain possibly originated from the USDA Poultry Research Lab in Georgia. Former CDC director Redfield mentioned that manipulating the virus could make it transmissible to humans. Interestingly, the director of the lab has ties to the Gates Foundation. This raises questions about the origins and implications of the outbreak.

The speaker, who has served in 5 administrations, discusses the issue of pandemic preparedness. They emphasize that the coming administration will face challenges in dealing with infectious diseases, including both chronic diseases and surprise outbreaks. The speaker highlights the importance of learning from past experiences, such as HIV, and stresses the need for substantial resources, involvement of communities, cross-sector collaboration, and engagement of leaders and policymakers. They assert that infectious diseases are a perpetual challenge that will not go away, and confidently state that such challenges will be seen in the next few years.

All countries experiencing H5 outbreaks in animals are urged to share viral samples and sequences with the WHO Global Influenza Surveillance and Response System (GISRIS).

The call brought together public health agencies to discuss HPAI H5N1 surveillance and research. CFIA presented enhanced poultry surveillance plans, while the UK Health Security Agency shared their asymptomatic human surveillance pilot. Don Sheppard from PHAC emphasized the need for developing an assay for H5N1 testing. Discussions revolved around the extent of surveillance, target populations, and assay validation challenges due to limited serum samples. Protocol development is underway to prepare for potential positive test results.

There is a lack of knowledge and organization regarding infectious diseases in this country, leading to panic and unreasonable plans. The fear of a highly contagious and deadly virus like avian flu caused unnecessary concern. However, the speaker explains that the flu cannot cause the same level of mortality as it did in the past due to various reasons. The contagiousness of respiratory diseases is limited, with each patient infecting an average of two people. The exaggerated response to these diseases, resembling a nuclear threat, should be managed by medical professionals rather than government agencies.

Mammals, including minks, otters, foxes, and sea lions, have been infected with H5N1 avian influenza. WHO is monitoring closely as the virus spreads from wild birds and poultry. The risk to humans is currently low, but we must be prepared for any changes. WHO is working with national authorities and partners to study human cases and ensure vaccine and antiviral supplies are available globally. Translation (if needed): Mammals like minks, otters, foxes, and sea lions have caught H5N1 avian flu. WHO is watching closely as it spreads from birds and poultry. The risk to people is low, but we need to be ready for any changes. WHO is collaborating with countries and partners to research human cases and ensure vaccines and antivirals are ready worldwide.

Research on bird flu in laboratories has raised significant concerns. At the Scripps Institute in California, funded by the Bill and Melinda Gates Foundation and NIH, scientists identified mutations that could enhance the virus's ability to infect humans, sharing their findings in the journal Science. Similarly, Yoshihiro Kawaoka at the University of Wisconsin has conducted gain-of-function research on bird flu for decades, experiencing multiple lab accidents with modified strains. In the Netherlands, Ron Fouchier at Erasmus Medical Center has been working on making bird flu airborne using ferrets. This ongoing research poses substantial risks, and there are calls to halt gain-of-function studies to prevent potential leaks and misuse of information.

In this video, the speaker discusses how certain strains of influenza are not included in PCR tests, such as the BSL 4 strain, h7n9, and h5n1. They question the effectiveness of testing millions of people without being able to detect these specific strains. The speaker also mentions Kristin Drosten and refers to this situation as an "evil genius" move.

I will discuss pandemic preparedness today. Based on my experience, I can say that the next administration will face challenges with chronic infectious diseases and unexpected outbreaks. In my 32 years as NIAID director, history shows that these challenges are inevitable for the new administration.

There is an upcoming international bird flu summit in Washington DC that is not being covered by the media. The summit will discuss pandemic preparedness, civil unrest management, and isolation measures in correctional facilities. Keynote presenters from fire departments and first responders will be present. The event is online on October 2nd, but there is little public awareness. The speaker is concerned about the lack of information and urges people to ask questions and pay attention before the upcoming election.

I am Tiffany Doper, the manager of the COVID unit in CCU. My team will be among the first to receive the vaccine. Apologies, I am feeling dizzy.

The call brought together public health agencies to discuss the HPAI H5N1 trajectory, focusing on enhanced surveillance and scientific efforts. CFIA presented enhanced poultry surveillance plans, while the UK Health Security Agency discussed their asymptomatic human surveillance pilot. PHAC emphasized the need to develop an assay for H5N1 testing. Technical questions remain about assay validation and population testing techniques. Work is ongoing to address these challenges and ensure preparedness for potential positive cases.

Researchers have been working on making bird flu more contagious for humans through gain of function research. The virus mainly infects chickens and sometimes cattle. Chinese vaccination efforts in the 90s may have worsened the situation. The current strain, H5N1 avian influenza, has caused around 800-900 human cases with a high mortality rate in Southeast Asia. Recent US cases were easily treated. The virus is not a significant threat unless it starts spreading human to human. The recent strain may have originated from experiments on mallard ducks in Georgia, leading to its spread across states. The media has not questioned this spread caused by migratory waterfowl.

Hi, I'm Doctor Nick Coatsworth, an infectious diseases and respiratory physician. I'm here to provide the latest updates on COVID-19 vaccination. Register your interest today using the options available.